Dermatologic Manifestations of the Immune Reconstitution Inflammatory Syndrome

Dermatologic Clinics

Volumn 24, Issue 4, 2006, Pages 549-570

  Lehloenya, Rannakoe ^a   Meintjes, Graeme ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c GF Jooste Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; ERYTHROMYCIN; GANCICLOVIR; HYDROXYCHLOROQUINE; LEPROSTATIC AGENT; STEROID;

ACNE VULGARIS; ALOPECIA; CANCER RADIOTHERAPY; CANDIDIASIS; CHOROID DISEASE; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DYSHIDROSIS; ENCEPHALITIS; FOREIGN BODY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOGENESIS; INFECTION RISK; INFLAMMATORY DISEASE; IRITIS; KAPOSI SARCOMA; KERATITIS; LEISHMANIASIS; LEPROSY; MYELITIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REITER SYNDROME; RETINA NECROSIS; REVIEW; SARCOIDOSIS; SKIN MANIFESTATION; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TINEA CORPORIS; VERRUCA VULGARIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; HIV; HIV INFECTIONS; HUMANS; INFECTION; INFLAMMATION; SKIN DISEASES; SYNDROME; VIRAL LOAD;

EID: 33748945836     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2006.06.007     Document Type: Review

References (130)

1. Palella Jr. F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 13 (1998) 853-860
2. Coetzee D., Hildebrand K., Boulle A., et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18 6 (2004) 887-895
3. Egger M., May M., Chene G., et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360 9327 (2002) 119-129
4. Hogg R.S., Yip B., Chan K.J., et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 286 20 (2001) 2568-2577
5. Lawn S.D., Bekker L.G., and Miller R.F. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5 6 (2005) 361-373
6. Shelburne S.A., Montes M., and Hamill R.J. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 57 2 (2006) 167-170
7. Shelburne III S.A., Hamill R.J., Rodriguez-Barradas M.C., et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81 3 (2002) 213-227
8. French M.A., Price P., and Stone S.F. Immune restoration disease after antiretroviral therapy. AIDS 18 12 (2004) 1615-1627
9. Cheng V.C., Ho P.L., Lee R.A., et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21 11 (2002) 803-809
10. Hawkey C.R., Yap T., Pereira J., et al. Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis 40 9 (2005) 1368-1371
11. Shelburne III S.A., and Hamill R.J. The immune reconstitution inflammatory syndrome. AIDS Rev 5 2 (2003) 67-79
12. Smith H. Paradoxical responses during the chemotherapy of tuberculosis. J Infect 15 1 (1987) 1-3
13. French M.A., Mallal S.A., and Dawkins R.L. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 6 11 (1992) 1293-1297
14. French M.A., Lenzo N., John M., et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 1 2 (2000) 107-115
15. Narita M., Ashkin D., Hollender E.S., et al. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158 1 (1998) 157-161
16. Lortholary O., Fontanet A., Memain N., et al. French Cryptococcosis Study Group. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19 10 (2005) 1043-1049
17. Jenny-Avital E.R., and Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 35 12 (2002) e128-e133
18. Shelburne III S.A., Darcourt J., White Jr. A.C., et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 40 7 (2005) 1049-1052
19. Lawn S.D., Bekker L.G., Myer L., et al. Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS 19 17 (2005) 2050-2052
20. French M.A., Lewin S.R., Dykstra C., et al. Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction. AIDS Res Hum Retroviruses 20 2 (2004) 157-162
21. Silvestre J.F., Albares M.P., Ramon R., et al. Cutaneous intolerance to tattoos in a patient with human immunodeficiency virus: a manifestation of the immune restoration syndrome. Arch Dermatol 137 5 (2001) 669-670
22. Bower M., Nelson M., Young A.M., et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 23 22 (2005) 5224-5228
23. Naccache J.M., Antoine M., Wislez M., et al. Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med 159 6 (1999) 2009-2013
24. Blanche P., Passeron A., Gombert B., et al. Sarcoidosis and HIV infection: influence of highly active antiretroviral therapy. Br J Dermatol 140 6 (1999) 1185
25. Mirmirani P., Maurer T.A., Herndier B., et al. Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome. J Am Acad Dermatol 41 2 Pt 2 (1999) 285-286
26. Gomez V., Smith P.R., Burack J., et al. Sarcoidosis after antiretroviral therapy in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 31 5 (2000) 1278-1280
27. Trevenzoli M., Cattelan A.M., Marino F., et al. Sarcoidosis and HIV infection: a case report and a review of the literature. Postgrad Med J 79 935 (2003) 535-538
28. Lenner R., Bregman Z., Teirstein A.S., et al. Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy. Chest 119 3 (2001) 978-981
29. Haramati L.B., Lee G., Singh A., et al. Newly diagnosed pulmonary sarcoidosis in HIV-infected patients. Radiology 218 1 (2001) 242-246
30. Ratnam I., Chiu C., Kandala N.B., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 42 3 (2006) 418-427
31. Jevtovic D.J., Salemovic D., Ranin J., et al. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 6 2 (2005) 140-143
32. Puthanakit T., Oberdorfer P., Akarathum N., et al. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children. Pediatr Infect Dis J 25 1 (2006) 53-58
33. Osei-Sekyere B, Karstaedt AS. Immune reconstitution syndrome involving the skin [abstract ID P20]. In: Programme & abstract book of the 1st Joint Congress of Federation of Infectious Diseases Societies of Southern Africa. Sun City (South Africa): Remata Inathi; 2005. p. 33.
34. Sarazin E., Nacher M., Toure Y., et al. Dermatologic manifestations associated with immune reconstitution syndrome in HIV + patients starting HAART: a retrospective study in French Guiana. Bull Soc Pathol Exot 98 3 (2005) 187-192
35. Lederman M.M. Immune restoration and CD4 + T-cell function with antiretroviral therapies. AIDS 15 Suppl 2 (2001) S11-S15
36. Autran B. Effects of antiretroviral therapy on immune reconstitution. Antivir Ther 4 Suppl 3 (1999) 3-6
37. John M., and French M.A. Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Med J Aust 169 9 (1998) 473-474
38. Stone S.F., Price P., and French M.A. Immune restoration disease: a consequence of dysregulated immune responses after HAART. Curr HIV Res 2 3 (2004) 235-242
39. Price P., Morahan G., Huang D., et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 16 15 (2002) 2043-2047
40. Burman W, Khan A, Vernon A, et al, and the Tuberculosis Trials Consortium University North Texas. Immune reconstitution inflammatory reactions among patients with HIV-related tuberculosis [abstract 904]. In: Final Program and Abstracts Book of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston; 2004. p. 201-202. Available at: www.idsociety.org. Accessed August 21, 2006.
41. Olalla J., Pulido F., Rubio R., et al. Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease. Int J Tuberc Lung Dis 6 1 (2002) 71-75
42. Hirsch H.H., Kaufmann G., Sendi P., et al. Immune reconstitution in HIV-infected patients. Clin Infect Dis 38 8 (2004) 1159-1166
43. Hengge U.R., Franz B., and Goos M. Decline of infectious skin manifestations in the era of highly active antiretroviral therapy. AIDS 14 8 (2000) 1069-1070
44. Maurer T., Rodrigues L.K., Ameli N., et al. The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. Clin Infect Dis 38 4 (2004) 579-584
45. Dunic I., Vesic S., and Jevtovic D.J. Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy. HIV Med 5 1 (2004) 50-54
46. Hicks C.B., Myers S.A., and Giner J. Resolution of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir. Clin Infect Dis 24 5 (1997) 1023-1025
47. Fox P.A., Barton S.E., Francis N., et al. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med 1 1 (1999) 10-18
48. Reddy V., and Luzzi G.A. Chronic vulval ulceration-another immune reconstitution inflammatory syndrome?. Int J STD AIDS 16 6 (2005) 454-455
49. Naseri A., and Margolis T.P. Varicella zoster virus immune recovery stromal keratitis in a patient with AIDS. Br J Ophthalmol 85 11 (2001) 1390-1391
50. Rodriguez-Rosado R., Soriano V., Dona C., et al. Opportunistic infections shortly after beginning highly active antiretroviral therapy. Antivir Ther 3 4 (1998) 229-231
51. Domingo P., Torres O.H., Ris J., et al. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am J Med 110 8 (2001) 605-609
52. Aldeen T., Hay P., Davidson F., et al. Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy. AIDS 12 13 (1998) 1719-1720
53. Martinez E., Gatell J., Moran Y., et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 27 6 (1998) 1510-1513
54. Dunic I., Djurkovic-Djakovic O., Vesic S., et al. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors. Int J STD AIDS 16 7 (2005) 475-478
55. Tangsinmankong N., Kamchaisatian W., Lujan-Zilbermann J., et al. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. J Allergy Clin Immunol 113 4 (2004) 742-746
56. Clark B.M., Krueger R.G., Price P., et al. Compartmentalization of the immune response in varicella zoster virus immune restoration disease causing transverse myelitis. AIDS 18 8 (2004) 1218-1221
57. Michelet C., Arvieux C., Francois C., et al. Opportunistic infections occurring during highly active antiretroviral treatment. AIDS 12 14 (1998) 1815-1822
58. Leidner R.S., and Aboulafia D.M. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 19 10 (2005) 635-644
59. Crane H.M., Deubner H., Huang J.C., et al. Fatal Kaposi's sarcoma-associated immune reconstitution following HAART initiation. Int J STD AIDS 16 1 (2005) 80-83
60. Chan D.J. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation. Int J STD AIDS 17 1 (2006) 72
61. Weir A., and Wansbrough-Jones M. Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patient. AIDS 11 15 (1997) 1895-1896
62. Connick E., Kane M.A., White I.E., et al. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin Infect Dis 39 12 (2004) 1852-1855
63. Qazi N.A., Morlese J.F., Walsh J.C., et al. Case report. Severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART. AIDS Read 12 10 (2002) 452-454 456-7
64. Greenspan D., Canchola A.J., MacPhail L.A., et al. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 357 9266 (2001) 1411-1412
65. Patton L.L., McKaig R., Strauss R., et al. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89 3 (2000) 299-304
66. King M.D., Reznik D.A., O'Daniels C.M., et al. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 34 5 (2002) 641-648
67. Phillips P., Bonner S., Gataric N., et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 41 10 (2005) 1483-1497
68. Brown M., Williams I.G., and Miller R.F. Deterioration of disseminated cutaneous Mycobacterium avium complex infection with a leukaemoid reaction following institution of highly active antiretroviral therapy. Sex Transm Infect 77 2 (2001) 149-150
69. Lawn S.D., Bicanic T.A., and Macallan D.C. Pyomyositis and cutaneous abscesses due to Mycobacterium avium: an immune reconstitution manifestation in a patient with AIDS. Clin Infect Dis 38 3 (2004) 461-463
70. del Giudice P., Durant J., Counillon E., et al. Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome. Arch Dermatol 135 9 (1999) 1129-1130
71. Lawn S.D., Wood C., and Lockwood D.N. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis 36 1 (2003) e5-e6
72. Couppie P., Abel S., Voinchet H., et al. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol 140 8 (2004) 997-1000
73. Pignataro P., Rocha Ada S., Nery J.A., et al. Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 23 5 (2004) 408-411
74. Sotto A., Guillot B., Dandurand M., et al. Exacerbation of skin mycobacterial lesions under highly active antiretroviral therapy in an HIV-infected patient. AIDS 13 13 (1999) 1790-1791
75. Breton G., Duval X., Estellat C., et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 39 11 (2004) 1709-1712
76. Michailidis C., Pozniak A.L., Mandalia S., et al. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antivir Ther 10 3 (2005) 417-422
77. Maccari F., Descamps V., Duval X., et al. Skin manifestations of immune restoration syndrome in treated tuberculosis. Ann Dermatol Venereol 128 10 Pt 1 (2001) 1028-1030
78. Manfredi R., Pieri F., Pileri S.A., et al. The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review. Mycopathologia 148 2 (1999) 73-78
79. Gasiorowski J., Szybejko-Machaj G., and Machaj A. Cutaneous cryptococcosis in AIDS patient. Pol Merkuriusz Lek 10 60 (2001) 456-459
80. Shelburne III S.A., Visnegarwala F., Adams C., et al. Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy. Am J Med 118 9 (2005) 1038-1041
81. Breton G., Adle-Biassette H., Therby A., et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20 1 (2006) 119-121
82. van Hal S.J., and Kotsiou G. An HIV-positive man with generalized rash. Clin Infect Dis 40 1 (2005) 113, 182-3
83. Rajendran P.M., Dolev J.C., Heaphy Jr. M.R., et al. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. Arch Dermatol 141 10 (2005) 1227-1231
84. Bouscarat F., Maubec E., Matheron S., et al. Immune recovery inflammatory folliculitis. AIDS 14 5 (2000) 617-618
85. Delfos N.M., Collen A.F., and Kroon F.P. Demodex folliculitis: a skin manifestation of immune reconstitution disease. AIDS 18 4 (2004) 701-702
86. Kreuter A., Schlottmann R., Altmeyer P., et al. Acne vulgaris as an immune reconstitution syndrome in a patient with AIDS after initiation of antiretroviral therapy. J Eur Acad Dermatol Venereol 16 6 (2002) 638
87. Neumann S., Kreth F., Schubert S., et al. Reiter's syndrome as a manifestation of an immune reconstitution syndrome in an HIV-infected patient: successful treatment with doxycycline. Clin Infect Dis 36 12 (2003) 1628-1629
88. Posada-Vergara M.P., Lindoso J.A., Tolezano J.E., et al. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. J Infect Dis 192 10 (2005) 1819-1822
89. Ridolfo A.L., Gervasoni C., Antinori S., et al. Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum. J Infect 40 2 (2000) 199-202
90. Gilad J., Borer A., Hallel-Halevy D., et al. Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection. Isr Med Assoc J 3 6 (2001) 451-452
91. Farrant P., and Higgins E. A granulomatous response to tribal medicine as a feature of the immune reconstitution syndrome. Clin Exp Dermatol 29 4 (2004) 366-368
92. Murray C.A., DeKoven J., and Spaner D.E. Foreign body granuloma: a new manifestation of immune restoration syndrome. J Cutan Med Surg 7 1 (2003) 38-42
93. Diri E., Lipsky P.E., and Berggren R.E. Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 27 11 (2000) 2711-2714
94. Chamberlain A.J., Hollowood K., Turner R.J., et al. Tumid lupus erythematosus occurring following highly active antiretroviral therapy for HIV infection: a manifestation of immune restoration. J Am Acad Dermatol 51 5 Suppl (2004) S161-S165
95. Sereti I., Sarlis N.J., Arioglu E., et al. Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy. AIDS 15 1 (2001) 138-140
96. Bachmeyer C., Cordier F., Blum L., et al. Multiple eruptive dermatofibromas after highly active antiretroviral therapy. Br J Dermatol 143 6 (2000) 1336-1337
97. Colebunders R., Zolfo M., and Lynen L. Severe dyshidrosis in two patients with HIV infection shortly after starting highly active antiretroviral treatment. Dermatol Online J 11 2 (2005) 31
98. Glesby M.J., Moore R.D., and Chaisson R.E. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis 21 2 (1995) 370-375
99. Rogues A.M., Dupon M., Ladner J., et al. Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. Groupe d'Epidemiologie clinique du SIDA en Aquitaine. J Infect Dis 168 1 (1993) 245
100. Buchbinder S.P., Katz M.H., Hessol N.A., et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 166 5 (1992) 1153-1156
101. Veenstra J., Krol A., van Praag R.M., et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS 9 10 (1995) 1153-1158
102. Whitley R.J., and Gnann Jr. J.W. Herpes zoster in patients with human immunodeficiency virus infection-an ever-expanding spectrum of disease. Clin Infect Dis 21 4 (1995) 989-990
103. Boshoff C., and Weiss R. AIDS-related malignancies. Nat Rev Cancer 2 5 (2002) 373-382
104. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92 22 (2000) 1823-1830
105. Cattelan A.M., Calabro M.L., Aversa S.M., et al. Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. Eur J Cancer 35 13 (1999) 1809-1815
106. Holkova B., Takeshita K., Cheng D.M., et al. Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol 19 18 (2001) 3848-3851
107. Toyohama T., Nagasaki A., Miyagi J., et al. Kaposi's sarcoma in a human immunodeficiency virus-negative patient treated with corticosteroid for idiopathic thrombocytopenic purpura. Intern Med 42 5 (2003) 448-449
108. Elliott A.M., Luzze H., Quigley M.A., et al. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J Infect Dis 190 5 (2004) 869-878
109. Quinlivan E.B., Zhang C., Stewart P.W., et al. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis 185 12 (2002) 1736-1744
110. Imami N., Antonopoulos C., Hardy G.A., et al. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 15 17 (1999) 1499-1508
111. Albini T., and Rao N. Molluscum contagiosum in an immune reconstituted AIDS patient. Br J Ophthalmol 87 11 (2003) 1427-1428
112. Hurni M.A., Bohlen L., Furrer H., et al. Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined antiretroviral therapy with saquinavir, zidovudine and lamivudine. AIDS 11 14 (1997) 1784-1785
113. Horn C.K., Scott G.R., and Benton E.C. Resolution of severe molluscum contagiosum on effective antiretroviral therapy. Br J Dermatol 138 4 (1998) 715-717
114. Rodrigues L.K., Baker T., and Maurer T. Cutaneous warts in HIV-positive patients undergoing highly active antiretroviral therapy. Arch Dermatol 137 8 (2001) 1103-1104
115. Spach D.H., and Colven R. Resolution of recalcitrant hand warts in an HIV-infected patient treated with potent antiretroviral therapy. J Am Acad Dermatol 40 5 Pt 2 (1999) 818-821
116. Barbaro D.J., Orcutt V.L., and Coldiron B.M. Mycobacterium avium-Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS. Rev Infect Dis 11 4 (1989) 625-628
117. Bwire R., and Kawuma H.J. Type 1 reactions in leprosy, neuritis and steroid therapy: the impact of the human immunodeficiency virus. Trans R Soc Trop Med Hyg 88 3 (1994) 315-316
118. Murray H.W. Kala-azar as an AIDS-related opportunistic infection. AIDS Patient Care STDS 13 8 (1999) 459-465
119. Jaliman H.D., Phelps R.G., and Fleischmajer R. Eosinophilic pustular folliculitis. J Am Acad Dermatol 14 3 (1986) 479-482
120. Porras B., Costner M., Friedman-Kien A.E., et al. Update on cutaneous manifestations of HIV infection. Med Clin North Am 82 5 (1998) 1033-1080
121. Costner M., and Cockerell C.J. The changing spectrum of the cutaneous manifestations of HIV disease. Arch Dermatol 134 10 (1998) 1290-1292
122. Lowery W.S., Whitlock W.L., Dietrich R.A., et al. Sarcoidosis complicated by HIV infection: three case reports and a review of the literature. Am Rev Respir Dis 142 4 (1990) 887-889
123. Gormand F., Pacheco Y., Trepo C., et al. The association of sarcoidosis and AIDS. Presse Med 18 7 (1989) 361
124. Kalter S., and Lopez-Berestein G. Acquired immune deficiency syndrome in a patient with prior sarcoidosis: case report with monocyte function studies. Tex Med 81 9 (1985) 44-46
125. Molina J.F., Citera G., Rosler D., et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol 22 2 (1995) 347-350
126. Furie R.A. Effects of human immunodeficiency virus infection on the expression of rheumatic illness. Rheum Dis Clin North Am 17 1 (1991) 177-188
127. Behrens G., Knuth C., Schedel I., et al. Highly active antiretroviral therapy. Lancet 351 9108 (1998) 1057-1058
128. Kuhn A., Richter-Hintz D., Oslislo C., et al. Lupus erythematosus tumidus-a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 136 8 (2000) 1033-1041
129. Dekle C.L., Mannes K.D., Davis L.S., et al. Lupus tumidus. J Am Acad Dermatol 41 2 Pt 1 (1999) 250-253
130. Elliott A.M., Halwiindi B., Bagshawe A., et al. Use of prednisolone in the treatment of HIV-positive tuberculosis patients. Q J Med 85 307-308 (1992) 855-860